Form 4 for PHIO Phio Pharmaceuticals Corp.
Accepted 2025-06-11 00:00:00 ET · period of report 2025-06-10 · accession 0001062993-25-011423 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-11 | 2025-06-10 | PHIO | Ferrara Robert L | Dir | P - Purchase | $2.42 | +2,500 | 15.7K | +19% | +$6,050 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, $0.0001 par value | 2025-06-10 | P | A | 2,500 | $2.42 | 15,666 | D | — | — | (F1) Includes shares of common stock underlying unvested restricted stock units. |